Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Efficacy and Safety of Spironolactone in Patients with Resistant Hypertension: A Meta-analysis of Randomised Controlled Trials
Chunbin Wang, Bo Xiong, Jing Huang
Heart Lung and Circulation (2016) Vol. 25, Iss. 10, pp. 1021-1030
Closed Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

2018 ESC/ESH Guidelines for the management of arterial hypertension
Bryan Williams, Giuseppe Mancia, Wilko Spiering, et al.
European Heart Journal (2018) Vol. 39, Iss. 33, pp. 3021-3104
Open Access | Times Cited: 8813
2018 ESC/ESH Guidelines for the management of arterial hypertension
Bryan Williams, Giuseppe Mancia, Wilko Spiering, et al.
Journal of Hypertension (2018) Vol. 36, Iss. 10, pp. 1953-2041
Open Access | Times Cited: 2578
Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association
Robert M. Carey, David A. Calhoun, George L. Bakris, et al.
Hypertension (2018) Vol. 72, Iss. 5
Open Access | Times Cited: 854
Arterial hypertension in adults. Clinical guidelines 2020
Zhanna Kobalava, А. О. Конради, С. В. Недогода, et al.
Russian Journal of Cardiology (2020) Vol. 25, Iss. 3, pp. 3786-3786
Open Access | Times Cited: 484
Prevalence of Apparent Treatment-Resistant Hypertension in the United States
Robert M. Carey, Swati Sakhuja, David A. Calhoun, et al.
Hypertension (2019) Vol. 73, Iss. 2, pp. 424-431
Open Access | Times Cited: 173
Hypertension management in patients with cardiovascular comorbidities
Lucas Lauder, Felix Mahfoud, Michel Azizi, et al.
European Heart Journal (2022) Vol. 44, Iss. 23, pp. 2066-2077
Open Access | Times Cited: 102
2024 Clinical practice guidelines for Hypertension in adults
Ж. Д. Кобалава, А. О. Конради, С. В. Недогода, et al.
Russian Journal of Cardiology (2024) Vol. 29, Iss. 9, pp. 6117-6117
Open Access | Times Cited: 20
Nocturnal Hypertension and Heart Failure: Mechanisms, Evidence, and New Treatments
Kazuomi Kario, Bryan Williams
Hypertension (2021) Vol. 78, Iss. 3, pp. 564-577
Open Access | Times Cited: 63
Occurrence and potential risk of steroid hormones in selected surface water and wastewater treatment plants in western Kenya
Isaac Cheruiyot Tanui, Faith Jebiwot Kandie, Martin Krauß, et al.
Environmental Pollution (2025) Vol. 367, pp. 125623-125623
Open Access | Times Cited: 1
PREVALENCE OF CORONARY ARTERY DISEASE IN YOUNG AND MIDDLE AGE PATIENTS WITH RESISTANT ARTERIAL HYPERTENSION
KH.YO. SHARIPOVA, D.D. RAKHIMOV, R.G. SOKHIBOV, et al.
Avicenna Bulletin (2022) Vol. 24, Iss. 3, pp. 317-323
Open Access | Times Cited: 29
Safety and efficacy of renal sympathetic denervation: a 9-year long-term follow-up of 24-hour ambulatory blood pressure measurements
Alexander Vogt, Jochen Dutzmann, Michael Nußbaum, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 17
Current Perspectives on Systemic Hypertension in Heart Failure with Preserved Ejection Fraction
Marty Tam, Ran Lee, Thomas Cascino, et al.
Current Hypertension Reports (2017) Vol. 19, Iss. 2
Open Access | Times Cited: 49
2018 ESC/ESH Guidelines for the management of arterial hypertension

Revista Española de Cardiología (2019) Vol. 72, Iss. 2, pp. 160.e1-160.e78
Open Access | Times Cited: 48
Spironolactone
Laura Carone, Stephen G. Oxberry, Robert Twycross, et al.
Journal of Pain and Symptom Management (2016) Vol. 53, Iss. 2, pp. 288-292
Open Access | Times Cited: 46
Risk of heart failure in ambulatory resistant hypertension: a meta-analysis of observational studies
Francesca Coccina, Gil F. Salles, José R. Banegas, et al.
Hypertension Research (2024) Vol. 47, Iss. 5, pp. 1235-1245
Open Access | Times Cited: 4
Eplerenone Versus Spironolactone in Resistant Hypertension: an Efficacy and/or Cost or Just a Men’s Issue?
Antonis A. Manolis, Theodora A. Manolis, Helen Melita, et al.
Current Hypertension Reports (2019) Vol. 21, Iss. 3
Closed Access | Times Cited: 34
The antihypertensive efficacy of a quadruple single-pill combination in patients with resistant hypertension: study protocol for a randomized, open-label, crossover trial
Yuanyuan Yao, Xin Zhang, Runyu Ye, et al.
Trials (2025) Vol. 26, Iss. 1
Open Access
Management of drug-resistant hypertension as a heterogeneous disorder
Reza Tabrizchi
Pharmacology & Therapeutics (2025), pp. 108875-108875
Closed Access
This synopsis summarizes key features of a joint VA/DoD guideline on diagnosis and management of hypertension in the primary care setting.
CDR Mark P. Tschanz, William C. Cushman, Travis Harrell, et al.
Annals of Internal Medicine (2020) Vol. 173, Iss. 11, pp. 904-913
Closed Access | Times Cited: 27
Posicionamento Brasileiro sobre Hipertensão Arterial Resistente – 2020
Juan Carlos Yugar‐Toledo, Heitor Moreno, Miguel Gus, et al.
Arquivos Brasileiros de Cardiologia (2020)
Open Access | Times Cited: 21
Cardiovascular Prognosis in Drug-Resistant Hypertension Stratified by 24-Hour Ambulatory Blood Pressure: The JAMP Study
Kazuomi Kario, Satoshi Hoshide, Keisuke Narita, et al.
Hypertension (2021) Vol. 78, Iss. 6, pp. 1781-1790
Open Access | Times Cited: 20
Efficacy of pharmacological and interventional treatment for resistant hypertension: a network meta-analysis
Zhejia Tian, Clara Vollmer Barbosa, Hannah Lang, et al.
Cardiovascular Research (2023) Vol. 120, Iss. 1, pp. 108-119
Open Access | Times Cited: 7
Recent advances in understanding and managing resistant/refractory hypertension
Michael Doumas, Κonstantinos Imprialos, Manolis S. Kallistratos, et al.
F1000Research (2020) Vol. 9, pp. 169-169
Open Access | Times Cited: 19
Effect of mineralocorticoid antagonists on blood pressure lowering
George Bazoukis, Costas Thomopoulos, Costas Tsioufis
Journal of Hypertension (2018) Vol. 36, Iss. 5, pp. 987-994
Closed Access | Times Cited: 20
Resistant Hypertension Updated Guidelines
Irene Chernova, Namrata Krishnan
Current Cardiology Reports (2019) Vol. 21, Iss. 10
Closed Access | Times Cited: 19
Page 1 - Next Page

Scroll to top